The hysteroscopic morcellator versus the bipolar resectoscope for removal of larger intrauterine polyps: a randomized controlled trial.

The hysteroscopic morcellator versus the bipolar resectoscope for removal of larger intrauterine polyps: a randomized controlled trial. - Hysteroscopic morcellator versus bipolar resectoscope for polypectomy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON38073

Enrollment

Registered

2011-01-18

Start date

2011-07-27

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometrial polyp swelling of the inner lining of the womb

Interventions

Patients are randomized between removal with the HM or the bipolar resectoscope.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with one or more intrauterine polyp(s) with a diameter >= 1 cm as seen on ultrasound, confirmed by saline infusion sonography and/or ambulant diagnostic hysteroscopy who are planned for hysteroscopic surgery.

Exclusion criteria

Exclusion criteria: Patients with: • Only polyps

Design outcomes

Primary

Measure	Time frame
Installation and operating time.	—

Secondary

Measure	Time frame
Comparing data on peri- and post operative complications (e.g. fluid deficit, conversion rates, perforation, burns, postoperative infection), availability of tissue for pathology analysis and pathology results, and efficiency at 6 weeks follow-up.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)